Table 3.
Univariable and Multivariable Analyses on Survival
Variable | Category | Univariable |
Multivariable |
||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | ||
Sex | Male/female | 0.91 | 0.66 to 1.26 | .6 | 0.87 | 0.57 to 1.33 | .5 |
Smoking | Smoker/never smoker | 1.28 | 0.81 to 2.04 | .3 | 1.24 | 0.69 to 2.25 | .5* |
Histology | Adenocarcinoma†/other | 0.97 | 0.75 to 1.25 | .8 | 1.02 | 0.76 to 1.38 | .9 |
Grade | I + II/III | 0.78 | 0.60 to 1.01 | .06 | 0.89 | 0.66 to 1.20 | .4 |
Stage | I + II/III + IV | 0.40 | 0.31 to 0.51 | < .0001‡ | 0.42 | 0.31 to 0.56 | < .0001‡ |
MET FISH | < 5/≥ 5 copies | 0.59 | 0.41 to 0.85 | .005‡ | 0.66 | 0.43 to 0.99 | .04‡ |
EGFR FISH | Negative/positive | 0.89 | 0.67 to 1.17 | .34 | 1.02 | 0.74 to 1.39 | .9 |
Abbreviations: HR, hazard ratio; FISH, fluorescent in situ hybridization; EGFR, epidermal growth factor receptor.
Sex, smoking status, histology, grade, and EGFR FISH variables were removed from the model at the last step of multivariable analysis.
Adenocarcinoma category also included bronchioloalveolar histology.
Statistically significant.